Literature DB >> 15884397

Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].

Samuel Komoly1.   

Abstract

BACKGROUND AND
PURPOSE: Heterogeneity of multiple sclerosis lesions has been recently indicated: In addition to T-cell-mediated or T-cell plus antibody-mediated autoimmune mechanisms (patterns I-II) two other patterns (IIl-IV) were described. Patterns Ill-IV are characterized by primary oligodendrocyte dystrophy, reminiscent of virus- or toxin-induced demyelination rather than autoimmunity. It was described more than 30 years ago that dietary application of a copper-chelating agent called cuprizone results in primary oligodendrocyte degeneration which is followed by demyelination. The aim of the present study was to examine the regional distribution of cuprizone induced oligodendrocyte dystrophy and demyelination in the nervous system of mice. MATERIAL A
METHODS: Demyelination was induced in male weanling Swiss-Webster mice by feeding them on a diet containing 0.6% (W/W) cuprizone bis(cyclohexanone)-oxalyldihydrazone (G. F. Smith Chemical, Columbus OH) for 8 weeks. Animals were sacrificed after 3, 7, 14, 27, 35, 56 days of cuprizone administration. Samples were taken from corpus callosum, anterior commissure, optic nerve, cervical spinal cord and sciatic nerve. Samples were examined by immunohistochemistry, in situ hybridization for myelin proteins and myelin protein mRNA-s, respectively. Conventional neuropathological stainings and electron microscopy was also performed.
RESULTS: Oligodendrocyte degeneration and demyelination followed a particular standard pattern in the central nervous system. Profound myelin loss developed in the superior cerebellar peduncle, anterior commissure and corpus callosum, whereas the optic nerves, velum medullare anterior and spinal cord showed little or no demyelination. Sciatic nerves were unaffected. No infiltration by lymphocytes or blood-brain barrier damage was observed during cuprizone treatment.
CONCLUSION: Cuprizone induced oligodendrocyte damage and demyelination follows a particular standard pattern in the central nervous system of mice. Cuprizone induced demyelination might be considered as a model for human demyelinating disorders with primary oligodendrocyte dystrophy and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15884397

Source DB:  PubMed          Journal:  Ideggyogy Sz        ISSN: 0019-1442            Impact factor:   0.427


  10 in total

Review 1.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

Review 2.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

3.  Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging.

Authors:  Laura-Adela Harsan; Jérôme Steibel; Anita Zaremba; Arnaud Agin; Rémy Sapin; Patrick Poulet; Blandine Guignard; Nathalie Parizel; Daniel Grucker; Nelly Boehm; Robert H Miller; M Said Ghandour
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

Review 4.  Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.

Authors:  Patrizia Casaccia-Bonnefil; Giovanna Pandozy; Fabrizio Mastronardi
Journal:  Prog Neurobiol       Date:  2008-09-26       Impact factor: 11.685

5.  Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.

Authors:  Angela Groebe; Tim Clarner; Werner Baumgartner; Jon Dang; Cordian Beyer; Markus Kipp
Journal:  Cerebellum       Date:  2009-03-04       Impact factor: 3.847

6.  Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination.

Authors:  Mangala M Soundarapandian; Vimal Selvaraj; U-Ging Lo; Mari S Golub; Daniel H Feldman; David E Pleasure; Wenbin Deng
Journal:  Sci Rep       Date:  2011-06-14       Impact factor: 4.379

7.  Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.

Authors:  Izabella Solti; Krisztian Kvell; Gergely Talaber; Sara Veto; Peter Acs; Ferenc Gallyas; Zsolt Illes; Katalin Fekete; Petra Zalan; Arpad Szanto; Zita Bognar
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

8.  An Alternative Cuprizone-Induced Demyelination and Remyelination Mouse Model.

Authors:  Wei Zhen; Ailian Liu; Jiaqi Lu; Wandong Zhang; David Tattersall; Jianfei Wang
Journal:  ASN Neuro       Date:  2017 Jul-Aug       Impact factor: 4.146

Review 9.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.

Authors:  Viktoria Gudi; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Cell Neurosci       Date:  2014-03-13       Impact factor: 5.505

10.  Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration.

Authors:  John Shelestak; Naveen Singhal; Lana Frankle; Riely Tomor; Sarah Sternbach; Jennifer McDonough; Ernest Freeman; Robert Clements
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.